Nasal spray flu vaccine becoming available

Oct 02, 2009 By LAURAN NEERGAARD , AP Medical Writer
A sign offering regular flu shots hangs on a Carr's grocery store in Anchorage, Alaska Wednesday Sept. 30, 2009. Department of Health and Social Services spokesman Greg Wilkinson says the first doses of swine flu vaccine may not reach state health centers until the week of Oct. 12 and decisions on distribution will be made on a community-by-community basis. (AP Photo/Al Grillo)

(AP) -- The long-awaited first vaccinations against swine flu - the squirt-in-the-nose kind - begin early next week in parts of the country, and states are urging people to be patient until more arrives.

Just a trickle of , 600,000 doses of the nasal spray FluMist, will be divided among 21 states and four large cities by Tuesday, with more small shipments to more states later in the week.

"We're moving this out as quickly as we can," said Oregon's public health director, Dr. Mel Kohn, who hopes shipments arrive in time to begin some vaccinations on Monday. "This doesn't do any good sitting in a warehouse."

Most states are aiming their first small batches at health care workers, hoping to keep them well enough to be on the job as cases of swine flu - what doctors prefer to call the 2009 H1N1 strain - are rapidly increasing nationwide.

In Chicago, firefighters will share first doses with hospitals, to get some emergency responders protected, too.

Alaska wants its meager first 4,000 FluMist doses to head directly to preschoolers, ages 2 to 4.

And Pennsylvania will target its initial 58,000 FluMist doses mostly to 5- to 9-year-olds in parts of the state where H1N1 is most active. It's the school-age kids who are getting infected most, said Pennsylvania's acting physician general, Dr. Stephen Ostroff, and the under-10 crowd is going to need two doses of .

"Our figuring is, let's get started in the group that's going to take longest to get protected," he said.

Stay tuned: How much vaccine is available and for whom is going to change week by week.

"This is really just the beginning," said Dr. Anne Schuchat of the U.S. . "We need a little bit of patience the first couple of weeks."

Indeed, some states were surprised that the first shipments were FluMist, which is only for healthy people ages 2 to 49, which leaves out some of the groups at high risk for H1N1 flu.

The more common flu shot will be close behind, part of the 6 million to 7 million doses of vaccine the CDC expects to ship around the country by the end of next week.

Far larger batches - about 40 million doses - start shipping the second week of October. That's when states expect enough of both shots and FluMist to start heavily targeting the high-risk groups: pregnant women, children and young adults from 6 months to 24 years, the young and middle-aged who have flu-risky conditions like asthma or diabetes, and caregivers of infants.

Hospitals in Pinellas County, Fla., plan to give new parents a special reminder. On the newborn checklist - infant car seat, going-home outfit - comes a plea to get themselves vaccinated before discharge. Because newborns can't be vaccinated, "the only way to protect your baby is for Mom, Dad and the family to receive the vaccine," the flyer says.

By the end of October, Arizona expects 1 million doses on hand, enough for schools to start onsite vaccination programs, said Health Services Director Will Humble.

What about everybody else? Massachusetts officials are warning that people who aren't at high risk from may have to wait until November for an H1N1 shot.

In other states, officials are more optimistic. Milwaukee has earmarked its first shipment for health workers and its second for schoolchildren, kindergarten through high school.

Then by late October, "we should be able to open it up to anyone who wants it," said Milwaukee's disease-control chief, Paul Biedrzycki. "We're expecting two to three times the demand for seasonal flu vaccines."

This year brings an unusually complex vaccination schedule: Most people will need two different inoculations, one against regular winter flu and the H1N1 vaccine. Plus, children under 10 will need two H1N1 doses.

The federal government bought the nation's entire supply of H1N1 vaccine and is dividing doses as they arrive among states according to population. State health departments submit orders, and doses are shipped to the vaccination sites the states deemed able to quickly get shots into arms and squirts up noses - a mix of doctors' offices, hospitals, drugstores and public clinics. CDC in turn will track those shipments to see how fast vaccine is used, and for whom, to ensure the populations at highest risk are vaccinated.

©2009 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Explore further: FDA approves hard-to-abuse narcotic painkiller

add to favorites email to friend print save as pdf

Related Stories

Flu season: How many shots?

Aug 30, 2009

(AP) -- Doctors don't know yet if it will take one dose or two of vaccine to protect against the new swine flu. Add that to vaccine for the regular winter flu, and it could be a multishot season for a lot of people - or ...

US expects far fewer swine flu shots in October

Aug 18, 2009

(AP) -- The U.S. won't have nearly as much swine flu vaccine ready by mid-October as long predicted - 45 million doses instead of the anticipated 120 million, a federal official said Monday.

Recommended for you

FDA approves hard-to-abuse narcotic painkiller

Jul 25, 2014

(HealthDay)—A new formulation of a powerful narcotic painkiller that discourages potential abusers from snorting or injecting the drug has been approved by the U.S. Food and Drug Administration.

Race affects opioid selection for cancer pain

Jul 25, 2014

(HealthDay)—Racial disparities exist in the type of opioid prescribed for cancer pain, according to a study published online July 21 in the Journal of Clinical Oncology.

FDA approves tough-to-abuse formulation of oxycodone

Jul 25, 2014

(HealthDay)—Targiniq ER (oxycodone hydrochloride and naloxone hydrochloride extended release) has been approved by the U.S. Food and Drug Administration as a long-term, around-the-clock treatment for severe ...

Tough-to-abuse formulation of oxycodone approved

Jul 25, 2014

(HealthDay)—Targiniq ER (oxycodone hydrochloride and naloxone hydrochloride extended release) has been approved by the U.S. Food and Drug Administration as a long-term, around-the-clock treatment for severe pain when other ...

EU regulator: Morning-after pill OK for all women

Jul 24, 2014

(AP)—A commonly used morning-after pill is suitable for use by heavier women, the European Medicines Agency said Thursday after a review of the evidence sparked by the French manufacturer's declaration that the drugs didn't ...

Physicians warned about counterfeit medical devices

Jul 24, 2014

(HealthDay)—Physicians should be aware of the prevalence and serious consequences associated with use of counterfeit medical devices, according to a letter to the editor published online July 20 in Lasers in ...

User comments : 0